The 4th annual Physicians Transaction Conference is being held on March 24, which is during AAOS’ annual meeting (March 22-26), also in Chicago. It’s a 1-day, 9 CME credit event.
While at AAOS, Get Educated About Physician Group Transactions

This is a particularly timely seminar.
More orthopedic groups than ever are entering into partnerships with private equity firms, as evidenced by 30 orthopedic group transactions during 2021, doubling the number of orthopedic “investor platforms” from 7 at the end of 2020 to 14 today. And there were nearly 400 total physician group transactions in 2021 (up 89%), with even more expected in 2022.
The organizer of this seminar, the New Jersey law firm of Epstein, Becker and Green and one of its directors Gary W. Herschman (here is his Bio), have a program that is designed to educate orthopedic and spine physicians, surgeons and leaders of independent practices about:
- Why orthopedic groups are transacting with private equity
- How private equity deals allow surgeons to “monetize” the value of practice ownership
- Orthopedic group valuations in private equity transactions (and how to maximize)
- The “Pros and Cons” of private equity deals – from a panel of surgeons who transacted
- “Second Bite” transactions are “Real” – from a panel of surgeons who experienced them
- How to protect yourself (and your group) in a private equity transaction
Again, this Physician Transactions Conference will be held on March 24 at the University Club in Chicago.
It is an invitation only event. To learn more and to request an invitation (attendance is complementary but limited to physicians and leaders of independent medical groups, click here.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.